title: The window of opportunity in ACPA-positive rheumatoid arthritis is not explained by ACPA characteristics.
authors.forename: Annemiek
authors.initials: A
authors.lastname: Willemze
authors.forename: Michael P M
authors.initials: MP
authors.lastname: van der Linden
authors.forename: Saskia
authors.initials: S
authors.lastname: le Cessie
authors.forename: Leendert A
authors.initials: LA
authors.lastname: Trouw
authors.forename: Rene E M
authors.initials: RE
authors.lastname: Toes
authors.forename: Tom W J
authors.initials: TW
authors.lastname: Huizinga
authors.forename: Annette H M
authors.initials: AH
authors.lastname: van der Helm-van Mil
mesh_terms: D001172:Arthritis, Rheumatoid / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D042241:Early Diagnosis; D005500:Follow-Up Studies; D006801:Humans; D010456:Peptides, Cyclic / Q000276:immunology*; D011379:Prognosis
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide